Weight Loss
AOD-9604
AOD-9604 — clinical overview, dosing, side effects, and matched TN providers.
FDA Status
Not FDA-approved
Legal Status
Compounded availability varies
Key Benefits
- Placeholder benefit 1 (TODO)
- Placeholder benefit 2 (TODO)
Overview
Mechanism of Action
Dosing Protocol
Benefits
Side Effects & Contraindications
Legal & Regulatory Status in Tennessee
What to Ask Your TN Provider
Ready to talk to a licensed TN clinic about this peptide?
We'll match you with a Tennessee provider that fits your goals, budget, and location.
Commonly Stacked With
Weight Loss
Semaglutide
Once-weekly GLP-1 receptor agonist with 14.9% mean weight loss in STEP-1 and 20% cardiovascular event reduction in SELECT — the longest-studied molecule in modern weight management.
Read protocol →
Weight Loss
Tirzepatide
Once-weekly dual GIP/GLP-1 receptor agonist; the most effective FDA-approved weight management medication available today, with up to 22.5% mean body weight reduction in pivotal trials.
Read protocol →
Related Peptides
Weight Loss
Semaglutide
Once-weekly GLP-1 receptor agonist with 14.9% mean weight loss in STEP-1 and 20% cardiovascular event reduction in SELECT — the longest-studied molecule in modern weight management.
Read protocol →
Weight Loss
Tirzepatide
Once-weekly dual GIP/GLP-1 receptor agonist; the most effective FDA-approved weight management medication available today, with up to 22.5% mean body weight reduction in pivotal trials.
Read protocol →
Frequently Asked Questions
- AOD-9604's legal status: Compounded availability varies. Always work with a licensed Tennessee provider.
- Dosing varies — see the protocol section. TNPeptides.com does not prescribe.
- See the Side Effects & Contraindications section above. Talk to a provider before starting.